Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Association of Reference Pricing with Drug Selection and Spending.

Robinson JC, Whaley CM, Brown TT.

N Engl J Med. 2017 Aug 17;377(7):658-665. doi: 10.1056/NEJMsa1700087.

PMID:
28813219
2.

Effect of reducing cost sharing for outpatient care on children's inpatient services in Japan.

Kato H, Goto R.

Health Econ Rev. 2017 Aug 15;7(1):28. doi: 10.1186/s13561-017-0165-3.

3.
4.

Protocol for a randomised controlled trial evaluating the effects of providing essential medicines at no charge: the Carefully seLected and Easily Accessible at No Charge Medicines (CLEAN Meds) trial.

Persaud N, Lee T, Ahmad H, Li W, Taglione MS, Rajakulasingam Y, Umali N, Boozary A, Glazier RH, Gomes T, Hwang SW, Jüni P, Law M, Mamdani MM, Manns B, Martin D, Morgan S, Oh P, Pinto AD, Shah BR, Sullivan FM, Thorpe KE, Tu K, Laupacis A.

BMJ Open. 2017 Jun 12;7(5):e015686. doi: 10.1136/bmjopen-2016-015686.

5.

Impact of income-based deductibles on drug use and health care utilization among older adults.

Law MR, Cheng L, Worthington H, Mamdani M, McGrail KM, Chan FKI, Majumdar SR.

CMAJ. 2017 May 15;189(19):E690-E696. doi: 10.1503/cmaj.161119.

6.

Medicines Compliance and Reimbursement Level in Portugal.

Constantino Portela MDC, Campos Fernandes A.

Health Serv Res Manag Epidemiol. 2015 Aug 27;2:2333392815601972. doi: 10.1177/2333392815601972. eCollection 2015 Jan-Dec.

7.

Quality of Antiepileptic Treatment Among Older Medicare Beneficiaries With Epilepsy: A Retrospective Claims Data Analysis.

Pisu M, Richman J, Piper K, Martin R, Funkhouser E, Dai C, Juarez L, Szaflarski JP, Faught E.

Med Care. 2017 Jul;55(7):677-683. doi: 10.1097/MLR.0000000000000724.

PMID:
28437319
8.

Cost-related nonadherence to prescribed medicines among older Canadians in 2014: a cross-sectional analysis of a telephone survey.

Lee A, Morgan S.

CMAJ Open. 2017 Jan 17;5(1):E40-E44. doi: 10.9778/cmajo.20160126. eCollection 2017 Jan-Mar.

9.

Effect of cost sharing on adherence to evidence-based medications in patients with acute coronary syndrome.

González López-Valcárcel B, Librero J, García-Sempere A, Peña LM, Bauer S, Puig-Junoy J, Oliva J, Peiró S, Sanfélix-Gimeno G.

Heart. 2017 Jul;103(14):1082-1088. doi: 10.1136/heartjnl-2016-310610. Epub 2017 Mar 1.

10.

Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada.

Morgan SG, Li W, Yau B, Persaud N.

CMAJ. 2017 Feb 27;189(8):E295-E302. doi: 10.1503/cmaj.161082. Erratum in: CMAJ. 2017 Apr 3;189(13):E511.

11.

The effect of increasing the coinsurance rate on outpatient utilization of healthcare services in South Korea.

Lee HJ, Jang SI, Park EC.

BMC Health Serv Res. 2017 Feb 20;17(1):152. doi: 10.1186/s12913-017-2076-8.

12.

Exploring the impact of financial barriers on secondary prevention of heart disease.

Dhaliwal KK, King-Shier K, Manns BJ, Hemmelgarn BR, Stone JA, Campbell DJ.

BMC Cardiovasc Disord. 2017 Feb 14;17(1):61. doi: 10.1186/s12872-017-0495-4.

13.
14.

Medicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy.

Biggers A, Shi Y, Charlson J, Smith EC, Smallwood AJ, Nattinger AB, Laud PW, Neuner JM.

J Clin Oncol. 2016 Dec 20;34(36):4398-4404. Epub 2016 Oct 24.

15.

Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer.

Narang AK, Nicholas LH.

JAMA Oncol. 2017 Jun 1;3(6):757-765. doi: 10.1001/jamaoncol.2016.4865.

PMID:
27893028
16.

The Influence of Varying Cost Formats on Preferences.

Jiang CC, Fraenkel L.

Med Decis Making. 2017 Jan;37(1):17-26. Epub 2016 Nov 17.

PMID:
27856826
17.

Universal prescription drug coverage in Canada: Long-promised yet undelivered.

Morgan SG, Boothe K.

Healthc Manage Forum. 2016 Nov;29(6):247-254. Epub 2016 Oct 15. Review.

19.

Medication Nonadherence: The Role of Cost, Community, and Individual Factors.

Abbass I, Revere L, Mitchell J, Appari A.

Health Serv Res. 2017 Aug;52(4):1511-1533. doi: 10.1111/1475-6773.12547. Epub 2016 Aug 25.

PMID:
27558760
20.

Health insurance affects the use of disease-modifying therapy in multiple sclerosis.

Wang G, Marrie RA, Salter AR, Fox R, Cofield SS, Tyry T, Cutter GR.

Neurology. 2016 Jul 26;87(4):365-74. doi: 10.1212/WNL.0000000000002887. Epub 2016 Jun 29.

Supplemental Content

Support Center